Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quantumzyme (QTZM) EBT (2016 - 2026)

Quantumzyme (QTZM) has 6 years of EBT data on record, last reported at -$49868.0 in Q4 2025.

  • For Q4 2025, EBT rose 23.89% year-over-year to -$49868.0; the TTM value through Oct 2025 reached -$140675.0, down 54.2%, while the annual FY2025 figure was -$199269.0, 11.59% down from the prior year.
  • EBT reached -$49868.0 in Q4 2025 per QTZM's latest filing, up from -$65523.0 in the prior quarter.
  • Across five years, EBT topped out at -$49868.0 in Q4 2025 and bottomed at -$65523.0 in Q4 2024.